Abacavir
Generic name: Abacavir
Brand names: Ziagen
Drug class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Usage of Abacavir
Abacavir is an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying in your body.
Abacavir is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). abacavir is for adults and children who are at least 3 months old. Abacavir is not a cure for HIV or AIDS.
Abacavir may also be used for purposes not listed in this medication guide.
Abacavir side effects
Stop using abacavir and call your doctor at once if you have symptoms of an allergic reaction from two or more of these specific side effect groups:
Once you have had an allergic reaction to abacavir, you must never use it again. If you stop taking abacavir for any reason, talk to your doctor before you start taking the medication again.
Abacavir can cause other serious side effects that may not be signs of an allergic reaction. Call your doctor at once if you have:
Mild symptoms of lactic acidosis may worsen over time, and this condition can be fatal. Get emergency medical help if you have: unusual muscle pain, trouble breathing, stomach pain, vomiting, irregular heart rate, dizziness, feeling cold, or feeling very weak or tired.
Abacavir affects your immune system, which may cause certain side effects (even weeks or months after you've taken this medicine). Tell your doctor if you have:
Common side effects of abacavir may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Abacavir
You should not use abacavir if:
Many combination HIV medicines have abacavir as an ingredient. Ziagen should not be taken together with any other medicine that contains abacavir.
You may develop lactic acidosis, a dangerous build-up of lactic acid in your blood. This may be more likely if you have other medical conditions, if you've taken HIV medication for a long time, or if you are a woman. Ask your doctor about your risk.
Tell your doctor if you have ever had:
Tell your doctor if you are pregnant, and use your medications properly to control your infection. HIV can be passed to your baby if the virus is not controlled during pregnancy. Your name may be listed on a registry to track any effects of antiviral medicine on the baby.
Women with HIV or AIDS should not breastfeed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.
Relate drugs
- Adefovir
- Abacavir
- Baraclude
- Didanosine
- Emtricitabine
- Emtriva
- Entecavir
- Epivir
- Epivir A/F
- Epivir HBV
- Hepsera
- Lamivudine
- Retrovir (Zidovudine Intravenous)
- Retrovir (Zidovudine Oral)
- Retrovir oral/injection
- Stavudine
- Telbivudine
- Tenofovir
- Tenofovir alafenamide
- Tyzeka
- Vemlidy
- Videx
- Videx EC
- Videx Pediatric
- Viread
- Zerit
- Ziagen
- Zidovudine (Intravenous)
- Zidovudine (Oral)
- Zidovudine oral/injection
How to use Abacavir
Usual Adult Dose for HIV Infection:
300 mg orally twice a day or 600 mg orally once a dayUse: In combination with other antiretroviral agents, for the treatment of HIV-1 infection
Usual Adult Dose for Nonoccupational Exposure:
US CDC recommendations: 300 mg orally twice a day or 600 mg orally once a dayDuration of therapy: 28 daysComments:-Recommended as part of alternative regimens (NNRTI-based, protease inhibitor-based, or triple NRTI) for nonoccupational postexposure prophylaxis of HIV infection-Prophylaxis should be started as soon as possible, within 72 hours of exposure.-Current guidelines should be consulted for additional information.
Usual Adult Dose for Occupational Exposure:
US Public Health Service working group recommendations: 300 mg orally twice a day or 600 mg orally once a dayDuration of therapy: 28 days, if toleratedComments:-Only with expert consultation, as part of an alternative regimen for use as HIV postexposure prophylaxis-Prophylaxis should be started as soon as possible, preferably within hours after exposure.-The optimal duration of prophylaxis is unknown and may differ based on institution protocol.-Current guidelines should be consulted for additional information.
Usual Pediatric Dose for HIV Infection:
3 months or older:Oral solution: 8 mg/kg orally twice a day or 16 mg/kg orally once a dayMaximum dose: 600 mg/dayTablets:14 to less than 20 kg: 150 mg orally twice a day or 300 mg orally once a day20 to less than 25 kg: 150 mg orally in the morning and 300 mg in the evening, or 450 mg orally once a day25 kg or more: 300 mg orally twice a day or 600 mg orally once a dayUse: In combination with other antiretroviral agents, for the treatment of HIV-1 infection
Warnings
You should not take abacavir if you have ever had an allergic reaction to any medicine that contains abacavir, if you have moderate to severe liver disease, or if you have a gene variation called HLA-B*5701 allele.
Stop using abacavir and call your doctor at once if you have signs of an allergic reaction: fever; rash; nausea, vomiting, diarrhea, stomach pain; general ill feeling, extreme tiredness, body aches; shortness of breath, cough, sore throat.
You may develop lactic acidosis, a dangerous build-up of lactic acid in your blood. Call your doctor or get emergency medical help if you have unusual muscle pain, trouble breathing, stomach pain, dizziness, feeling cold, or feeling very weak or tired.
Abacavir can also cause severe or life-threatening effects on your liver. Call your doctor at once if you have pain or swelling in your upper stomach, tiredness, loss of appetite, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes).
What other drugs will affect Abacavir
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may affect abacavir, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions